ESALY实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (31 Jan 2023 @ 04:59):

Stats
今日成交量	331 859
平均成交量	30 263.00
市值	17.64B
EPS	$31.81 ( 2022-12-30 )
Last Dividend	$0.570 ( 2022-09-28 )
Next Dividend	$0 ( N/A )
P/E	20.54
ATR14	$2.32 (3.77%)

音量相关性

長: 0.00 (neutral)

短: -0.91 (very strong negative)

Signal:(39.154) Neutral

Eisai Co., Ltd. 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Eisai Co., Ltd. 相关性 - 货币/商品

0.73
( moderate )

0.33
( neutral )

-0.64
( weak negative )

0.76
( moderate )

-0.37
( neutral )

0.30
( neutral )

Eisai Co., Ltd. 财务报表

Annual	2022
营收:	$756.23B
毛利润:	$581.40B (76.88 %)
EPS:	$159.44

FY	2022
营收:	$756.23B
毛利润:	$581.40B (76.88 %)
EPS:	$159.44

FY	2021
营收:	$645.94B
毛利润:	$484.63B (75.03 %)
EPS:	$146.95

FY	2020
营收:	$695.62B
毛利润:	$519.93B (74.74 %)
EPS:	$425.01

Financial Reports:

No articles found.

Eisai Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.570 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Eisai Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 5.34 - average (45.15%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$1.110	2010-03-28
Last Dividend	$0.570	2022-09-28
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	26	--
Total Paid Out	$20.43	--
Avg. Dividend % Per Year	0.00%	--
Score	1.89	--
Div. Sustainability Score	5.34
Div.Growth Potential Score	0
Div. Directional Score	2.09	--

Next Divdend (Est)
(2024-07-02)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

1.89

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for OTC

Symbol	Title	Last dividend	Frequency	Yearly Dividend
SEBC	Ex Dividend Junior	2023-08-30	Quarterly	0.00%
FOTB	Ex Dividend Junior	2023-05-31	Semi-Annually	0.00%
MRRTY	Ex Dividend Junior	2023-09-08	Sporadic	0.00%
CNBB	Ex Dividend Knight	2023-09-28	Quarterly	0.00%
SWRAY	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
HKHHY	Ex Dividend Junior	2023-08-10	Annually	0.00%
AMNF	Ex Dividend Knight	2023-07-06	Quarterly	0.00%
ORBN	Ex Dividend Junior	2023-09-29	Quarterly	0.00%
CZBT	Ex Dividend Knight	2023-09-29	Quarterly	0.00%
TTNDF	Ex Dividend Knight	2023-08-29	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0358	1.500	9.28	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0104	1.200	9.65	10.00	[0 - 0.3]
returnOnEquityTTM	0.0162	1.500	-0.931	-1.397	[0.1 - 1]
payoutRatioTTM	1.772	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	1.945	0.800	5.27	4.22	[1 - 3]
quickRatioTTM	0.858	0.800	9.66	7.73	[0.8 - 2.5]
cashRatioTTM	0.854	1.500	6.36	9.55	[0.2 - 2]
debtRatioTTM	0.120	-1.500	8.00	-10.00	[0 - 0.6]
interestCoverageTTM	7.68	1.000	8.27	8.27	[3 - 30]
operatingCashFlowPerShareTTM	-103.59	2.00	-10.00	-10.00	[0 - 30]
freeCashFlowPerShareTTM	-145.33	2.00	-10.00	-10.00	[0 - 20]
debtEquityRatioTTM	0.194	-1.500	9.22	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.746	1.000	0.897	0.897	[0.2 - 0.8]
operatingProfitMarginTTM	0.0226	1.000	-1.547	-1.547	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.198	1.000	-2.21	-2.21	[0.2 - 2]
assetTurnoverTTM	0.289	0.800	-1.405	-1.124	[0.5 - 2]
Total Score				5.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	208.40	1.000	10.00	0	[1 - 100]
returnOnEquityTTM	0.0162	2.50	-0.599	-1.397	[0.1 - 1.5]
freeCashFlowPerShareTTM	-145.33	2.00	-10.00	-10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-103.59	2.00	-10.00	-10.00	[0 - 30]
payoutRatioTTM	1.772	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-0.0478	1.500	-3.65	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0821	1.000	-4.55	0	[0.1 - 0.5]
Total Score				-1.153

Eisai Co., Ltd.

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.